Literature DB >> 3884759

Renal hypophosphatemic rickets.

J C Chan, U Alon, G M Hirschman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884759     DOI: 10.1016/s0022-3476(85)80068-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  What is the risk of a lady with familial hypophosphatemic rickets having affected children and grandchildren.

Authors:  G Kainer; J C Chan
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

2.  Does growth hormone influence the severity of phosphopenic rickets?

Authors:  T Bistritzer; S A Chalew; A Hanukoglu; K M Armour; P J Haney; A A Kowarski
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

3.  X-linked dominant hypophosphatemia is closely linked to DNA markers DXS41 and DXS43 at Xp22.

Authors:  M Mächler; D Frey; A Gal; U Orth; T F Wienker; A Fanconi; W Schmid
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

Review 4.  Endocrine control and disturbances of calcium and phosphate metabolism in children.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

5.  Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.

Authors:  R Lanes; H E Harrison
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

6.  Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.

Authors:  Uri S Alon; Roshanak Monzavi; Marc Lilien; Majid Rasoulpour; Mitchell E Geffner; Ora Yadin
Journal:  Pediatr Nephrol       Date:  2003-01-18       Impact factor: 3.714

7.  Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets.

Authors:  G Saggese; G I Baroncelli; S Bertelloni; G Perri
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

Review 8.  Therapeutics of X-linked hypophosphatemic rickets.

Authors:  K Latta; S Hisano; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.